GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » Institutional Ownership

Oncimmune Holdings (LSE:ONC) Institutional Ownership : 3.95% (As of Apr. 15, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Oncimmune Holdings's institutional ownership is 3.95%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Oncimmune Holdings's Insider Ownership is 25.46%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Oncimmune Holdings's Float Percentage Of Total Shares Outstanding is 0.00%.


Oncimmune Holdings Institutional Ownership Historical Data

The historical data trend for Oncimmune Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings Institutional Ownership Chart

Oncimmune Holdings Historical Data

The historical data trend for Oncimmune Holdings can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31
Institutional Ownership 4.84 4.84 4.67 4.67 4.89 3.95 3.95 3.95 3.95 3.95

Oncimmune Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Oncimmune Holdings Business Description

Traded in Other Exchanges
N/A
Address
1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacturing, and commercialization of personalized immunodiagnostics for the screening, detection, and care of cancer. The company's operating segment is ImmunoINSIGHTS.